## Abstract The development of a calcium phosphate cement, comprising tetracalcium phosphate (TTCP) and dicalcium phosphate dihydrate (DCPD), that hardens in 14 min with water as the liquid or 6 min with a 0.25 mol/L sodium phosphate solution as the liquid, without using hydroxyapatite (HA) seeds a
Injectable and rapid-setting calcium phosphate bone cement with dicalcium phosphate dihydrate
✍ Scribed by Elena F. Burguera; Hockin H. K. Xu; Michael D. Weir
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 259 KB
- Volume
- 77B
- Category
- Article
- ISSN
- 1552-4973
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Calcium phosphate cement (CPC) sets in situ with intimate adaptation to the contours of defect surfaces, and forms an implant having a structure and composition similar to hydroxyapatite, the putative mineral in teeth and bones. The objective of the present study was to develop an injectable CPC using dicalcium phosphate dihydrate (DCPD) with a high solubility for rapid setting. Two agents were incorporated to impart injectability and fast‐hardening to the cement: a hardening accelerator (sodium phosphate) and a gelling agent (hydroxypropyl methylcellulose, HPMC). The cement with DCPD was designated as CPC~D~, and the conventional cement was referred to as CPC~A~. Using water without sodium phosphate, CPC~A~ had a setting time of 82 ± 6 min. In contrast, CPC~D~ exhibited rapid setting with a time of 17 ± 1 min. At 0.2 mol/L sodium phosphate, setting time for CPC~D~ was 15 ± 1 min, significantly faster than 40 ± 2 min for CPC~A~ (Tukey's at 0.95). Sodium phosphate decreased the paste injectability (measured as the paste mass extruded from the syringe divided by the original paste mass inside the syringe). However, the addition of HPMC dramatically increased the paste injectability. For CPC~D~, the injectability was increased from 65% ± 12% without HPMC to 98% ± 1% with 1% HPMC. Injectability of CPC~A~ was also doubled to 99% ± 1%. The injectable and rapid‐setting CPC~D~ possessed flexural strength and elastic modulus values overlapping the reported values for sintered porous hydroxyapatite implants and cancellous bone. In summary, the rapid setting and relatively high strength and elastic modulus of CPC~D~ should help the graft to quickly attain strength and geometrical integrity within a short period of time postoperatively. Furthermore, the injectability of CPC~D~ may have potential for procedures involving defects with limited accessibility or narrow cavities, when there is a need for precise placement of the paste, and when using minimally invasive surgical techniques. © 2005 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2006
📜 SIMILAR VOLUMES
## Abstract Calcium phosphate cement (CPC) sets __in situ__ to form resorbable hydroxyapatite with chemical and crystallographic similarity to the apatite in human bones, hence it is highly promising for clinical applications. The objective of the present study was to develop a CPC that is fast set
## Abstract Calcium phosphate bone cements are useful in orthopedics and traumatology, their main advantages being their biocompatibility and bioactivity, which render bone tissue osteoconductive, providing __in situ__ hardening and easy handling. However, their low mechanical strength, which, in t
## Abstract This work studied transmission electron microscopy on the setting mechanism of tetracalcium phosphate/dicalcium phosphate anhydrous (TTCP/DCPA)‐based calcium phosphate cement. The results suggest the process for early‐stage apatite formation as the follows: When TTCP and DCPA powders ar
Calcium phosphate cements (CPCs) with different amounts of tetracalcium phosphate (TTCP) and dicalcium phosphate anhydrous (DCPA) (TTCP/DCPA molar ratio from 0.25 to 2.00) were prepared to further understand the setting reaction and the factors that could influence the properties of CPCs. Quantitati
## Abstract The aim of this study was to determine the impact of barium sulfate on remodeling and regeneration in standard tibial defects in rabbits treated with the Norian skeletal repair system (SRS). Two formulations of SRS (with and without barium sulfate) were injected into the medullary canal